Remote Evaluation of MIND Diet

Remote Evaluation of MIND Diet

RecruitingNot a drug-phase studyMS (type not specified)NCT06450977

What it found

Still running

No result yet.

What was tested

Treatment tested

  • MIND Diet

Compared with

  • Control Diet

What it measured

Main measures

  • Information Processing

    12 weeks (Baseline vs. Follow Up)

  • Visual Processing

    12 weeks (Baseline vs. Follow Up)

  • Processing Speed

    12 weeks (Baseline vs. Follow Up)

    Thinking and memory

  • Learning

    12 weeks (Baseline vs. Follow Up)

  • Memory

    12 weeks (Baseline vs. Follow Up)

    Thinking and memory

  • MIND Scores

    12 weeks (Baseline vs. Follow Up)

    Quality of life (reported by participants)

Other measures (6)

  • Recruitment Rates

    Throughout the recruitment process

    Feasibility

  • Refusal Rates

    Throughout the recruitment process.

  • Retention rates

    Throughout the intervention (weeks 1-12)

    Feasibility

  • Attrition rates

    Throughout the intervention (weeks 1-12)

  • Adherence/Compliance Rates

    Throughout the intervention (weeks 1-12)

    Quality of life (reported by participants)

  • Participant Experience and Burden

    Throughout the intervention (weeks 1-12)

Who could take part

MS (type not specified) · 18 to 64

Show the full criteria

Inclusion criteria

1. Individuals aged 18-64 years old 2. Self-reported diagnosis of Multiple sclerosis (MS) 3. 20/20 or corrected vision 4. No other neurodegenerative disease diagnosis 5. Stable disease-modifying therapy (DMT) within 6 months 6. Not Pregnant or lactating 7. No food allergies or intolerances 8. Able to consume study meals 9. Not enrolled in another dietary, exercise, or medication study during the study 10. Access to a computer/laptop with internet

Exclusion criteria

1. Individuals younger than 18 or older than 64 years old 2. No self-reported diagnosis of Multiple sclerosis (MS) 3. Not 20/20 or uncorrected vision 4. Other neurodegenerative disease diagnosis 5. Disease modifying therapy (DMT) less than 6 months 6. Pregnant or lactating 7. Food allergies or intolerances 8. Not able to consume study meals 9. Enrolled in another dietary, exercise, or medication study during the study 10. No access to a computer/laptop with internet

As registered. Criteria can change, so ask the trial team or your neurologist.

Contact details on the registry

About this trial

In the sponsor's words

The goal of this clinical trial is to learn if increasing adherence to a Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) diet pattern improves thinking ability and memory compared to a healthy control diet in persons with Multiple Sclerosis (MS). The main question it aims to answer is: Does the MIND diet improve cognitive performance relative to a control diet in persons with MS? Participants will: Consume one meal that follows the MIND diet or a control meal every day for 3 months, complete online surveys and cognitive testing before and after, and keep a record of the food they eat during the study.

Papers

Loading reviews and guidelines…

History

    1. Started

      Jun 2024

    2. Main results due

      Jan 2026

    3. Finished

      Dec 2026

    Assembled by software from public sources.